Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001370053-25-000065
Filing Date
2025-08-06
Accepted
2025-08-06 16:24:30
Documents
15
Effectiveness Date
2025-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 forms-808062025.htm S-8 80524
2 EX-FILING FEES exfilingfees.htm   iXBRL EX-FILING FEES 19032
3 EX-5.1 anab-sx851opinionaugust2025.htm EX-5.1 11344
4 EX-23.2 kpmgconsent2025exhibit232.htm EX-23.2 1910
5 FW LOGO image_0.jpg GRAPHIC 9038
  Complete submission text file 0001370053-25-000065.txt   245167

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4789
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289301 | Film No.: 251190034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)